Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class ITerminatedSep 24, 2014Xzen 1200Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling Xzen 1200 because FDA laboratory analysis determined they...Nova Products, Inc. · D-1600-2014Class ITerminatedSep 24, 2014XZEN PLATINUMMarketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZEN PLATINUM because FDA laboratory analysis determined they...Nova Products, Inc. · D-1599-2014Class ITerminatedSep 24, 2014XZEN GOLDMarketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZEN GOLD because FDA laboratory analysis determined they...Nova Products, Inc. · D-1598-2014Class ITerminatedSep 24, 2014Black AntMarketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling Black Ant because FDA laboratory analysis determined they...Nova Products, Inc. · D-1597-2014Class ITerminatedSep 24, 2014AFRICAN BLACK ANTMarketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling AFRICAN BLACK ANT because FDA laboratory analysis determined...Nova Products, Inc. · D-1596-2014Class ITerminatedSep 24, 2014COUMADIN FOR INJECTIONPresence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vialsBristol-Meyers Squibb · D-1595-2014Class ITerminatedSep 24, 2014THINOGENICSMarketed Without an Approved NDA/ANDA: Product contains undeclared sibutramine.Nature's Universe · D-1594-2014Class ITerminatedSep 24, 2014Potassium Chloride InjectionPresence of Particulate Matter: particulate matter identified as fibers and/or plasticsBaxter Healthcare Corp. · D-1593-2014Class ITerminatedSep 24, 20140.9% Sodium Chloride Injection USP MINI-BAG Plus ContainerPresence of Particulate Matter: particulate matter identified as fibers and/or plastics.Baxter Healthcare Corp. · D-1592-2014Class ITerminatedSep 24, 20140.9% Sodium Chloride Injection USPPresence of Particulate Matter: particulate matter identified as fibers and/or plastics.Baxter Healthcare Corp. · D-1591-2014Class ITerminatedSep 24, 2014Oxcarbazepine TabletsLabeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that contain blister cards filled with Ibuprofen tablets, 600mg drug product, were...American Health Packaging · D-1590-2014Class ITerminatedSep 24, 2014Ibuprofen TabletsLabeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that contain blister cards filled with Ibuprofen tablets, 600mg drug product, were...American Health Packaging · D-1589-2014Class IITerminatedSep 24, 2014Bupivacaine HCl InjPresence of Particulate Matter: A confirmed customer complaint reported the presence of a brown, rust-colored particle embedded at the bottom of the glass vial.Hospira Inc. · D-1588-2014Class IITerminatedSep 24, 2014NORepinephrine 4 mg in 250 mL Sodium Chloride0.9%Lack of Assurance of Sterility: A mold like substance was discovered on the surface of an unopened bag of Sodium Chloride 0.9% while prepping the bag for production.Unique Pharmaceutical, Ltd · D-1587-2014Class IITerminatedSep 24, 2014Dermatend UltraLabeling: Labeling Bears Unapproved Claims; Dermatend is not FDA approved and therefore has not been shown to be safe and effective for the uses suggested in the...Solace International Inc · D-1586-2014Class IITerminatedSep 24, 2014Dermatend OriginalLabeling: Labeling Bears Unapproved Claims; Dermatend is not FDA approved and therefore has not been shown to be safe and effective for the uses suggested in the...Solace International Inc · D-1585-2014Class IIITerminatedSep 24, 2014Warfarin Sodium TabletsFailed Content Uniformity Specifications.Taro Pharmaceuticals U.S.A., Inc. · D-1584-2014Class IIITerminatedSep 24, 2014Candesartan Cilexetil and Hydrochlorothiazide Tablets 32 mg/12.5 mgFailed Impurity/Degradation Specification; high out of specification for CAD II degradantApotex Corp. · D-1570-2014Class IITerminatedSep 17, 20140.9% Sodium Chloride InjectionLack of Assurance of Sterility; complaints of mold in the overpouchBaxter Healthcare Corp. · D-1583-2014Class IIITerminatedSep 17, 2014CHIROTHIN Dietary SupplementMarketed without an Approved NDA/ANDA; Product contains unapproved hHCG.ChiroNutraceutical LLC · D-1569-2014Class IITerminatedSep 10, 2014PAXIL (Paroxetine HCL) Tablets 40 mgChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1582-2014Class IITerminatedSep 10, 2014PAXIL (Paroxetine HCL) Tablets 20 mgChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1581-2014Class IITerminatedSep 10, 2014PAXIL (Paroxetine HCL) Tablets 10 mgChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1580-2014Class IITerminatedSep 10, 2014PAXIL CRChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1579-2014Class IITerminatedSep 10, 2014PAXIL CRChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1578-2014Class IITerminatedSep 10, 2014Paroxetine HCL Controlled-Release Tablets 37.5 mgChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1577-2014Class IITerminatedSep 10, 2014Paroxetine HCL Controlled-Release Tablets 25 mgChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1576-2014Class IITerminatedSep 10, 2014PAXIL (Paroxetine HCL) Oral Suspension 10 mg/5 mL - 250 mL bottleChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1575-2014Class IITerminatedSep 10, 2014Paroxetine HCL Controlled-Release Tablets 12.5 mgChemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.Apotex Inc. · D-1574-2014Class IITerminatedSep 10, 2014Comfort Shield Barrier Cream Cloths with dimethicone a)Microbial Contamination of Non-Sterile Products: Comfort Shield Barrier Cream Cloth packages tested positive for bacterial contamination.Sage Products Inc · D-1573-2014Class IITerminatedSep 10, 2014OXYCODONE and ACETAMINOPHENFailed Tablet/Capsule Specifications: Broken tablets found in sealed bottles.Qualitest Pharmaceuticals · D-1572-2014Class ITerminatedSep 3, 2014Atropine Sulfate 0.4 mg/ml InjectionIncorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.Pharmakon Pharmaceuticals · D-1568-2014Class IITerminatedSep 3, 2014Glycopyrrolate 0.2 mg/mlIncorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.Pharmakon Pharmaceuticals · D-1567-2014Class ITerminatedSep 3, 2014Midazolam HCl 1 mg/ml in 0.9% Sodium Chloride in 50 mL and 100 mL IV bagIncorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.Pharmakon Pharmaceuticals · D-1566-2014Class ITerminatedSep 3, 2014Midazolam HCl 2 mg/ml in 0.9% Sodium Chloride in 30 mL PVC VialIncorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.Pharmakon Pharmaceuticals · D-1565-2014Class IITerminatedSep 3, 2014All Unexpired Sterile Drug ProductsLack of Assurance of SterilityAbrams Royal Pharamacy · D-1564-2014Class ITerminatedSep 3, 2014MINERAL IV InjectionNon-Sterility; analytical results found product to contain Sphingomonas paucimobilisAbrams Royal Pharamacy · D-1563-2014Class ITerminatedSep 3, 2014LOW Potassium Cardioplegia 792 mLNon Sterility; microbial contamination identified as Aspergillus speciesCentral Admixture Pharmacy Services, Inc. · D-1562-2014Class ITerminatedSep 3, 2014adenosine 90 mg in 0.9% sodium chloride/90 mLNon Sterility; microbial contamination identified as Aspergillus speciesCentral Admixture Pharmacy Services, Inc. · D-1561-2014Class ITerminatedSep 3, 2014del Nido Cardioplegia with Lidocaine 1052.8 mlNon Sterility; microbial contamination identified as Aspergillus speciesCentral Admixture Pharmacy Services, Inc. · D-1560-2014